Claritas Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average management tenure


CEO

Bob Farrell

5.83yrs

Tenure

US$300,000

Compensation

Mr. Robert Farrell, also known as Bob, J.D., serves as the President of Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) and has been its Chief Executive Officer since October 10, 2017...


CEO Compensation Analysis

How has Bob Farrell's remuneration changed compared to Claritas Pharmaceuticals's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2021n/an/a

US$2m

Jun 30 2021n/an/a

US$2m

Mar 31 2021n/an/a

-US$12m

Dec 31 2020US$300kUS$300k

US$4m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$875k

Dec 31 2019US$300kUS$300k

-US$21m

Sep 30 2019n/an/a

-US$12m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

US$2m

Dec 31 2018US$300kUS$300k

US$7m

Sep 30 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$24m

Mar 31 2018n/an/a

-US$32m

Dec 31 2017US$300kUS$300k

-US$32m

Sep 30 2017n/an/a

-US$14m

Jun 30 2017n/an/a

-US$13m

Mar 31 2017n/an/a

-US$13m

Dec 31 2016US$174kUS$174k

-US$12m

Compensation vs Market: Insufficient data to establish whether Bob's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Bob's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Robert Farrell
Chairman6.25yrsUS$300.00k0.26%
$ 2.5k
Victoria Rudman
Interim CFO7.58yrsUS$75.00kno data
Seth Yakatan
Co-Founderno dataUS$22.50kno data
Stuart Silverman
Co-Chair of Scientific Advisory Board and Vice President of Medical Affairsno datano datano data
Sari Prutchi-Sagiv
Chief Scientific Officer5.33yrsUS$212.00kno data
Moshe Yeshurun
Chief Medical Officer5.33yrsUS$162.00kno data
Amos Rosenthal
Head of Chemistryno datano datano data

5.8yrs

Average Tenure

54yo

Average Age

Experienced Management: CLAS's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert Farrell
Chairman5.83yrsUS$300.00k0.26%
$ 2.5k
Stuart Silverman
Co-Chair of Scientific Advisory Board and Vice President of Medical Affairs7yrsno datano data
Robert Langer
Member of Scientific Advisory Board6.33yrsno datano data
Andrew Salzman
Scientific Advisorno dataUS$596.03kno data
Raphael Mechoulam
Co-Chair of Scientific Advisory Boardno datano datano data
Yossi Tam
Member of Scientific Advisory Boardno datano datano data
Yanekl Gabet
Member of Scientific Advisory Boardno datano datano data
Deborah Kado
Member of Scientific Advisory Boardno datano datano data
Yong-Hui Jiang
Member of Scientific Advisory Boardno datano datano data
Joseph Lynch
Member of Strategic & Scientific Advisory Board4.42yrsno datano data
Salvatore Cuzzocrea
Independent Director1.58yrsno datano data
Perenlei Enkhbaatar
Independent Director1.58yrsno datano data

5.1yrs

Average Tenure

73yo

Average Age

Experienced Board: CLAS's board of directors are considered experienced (5.1 years average tenure).